Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Nutricia Foundation | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is designed to assess the effect of oligofructose administration for 12 weeks on Body Mass Index (BMI) of overweight and obese children.
The prevalence of childhood overweight and obesity is reaching epidemic proportions. There have been no effective methods for preventing or treating obesity in childhood so far prompting interest in new interventions. One potential option for obesity prevention is the use of the prebiotic oligofructose. Data from research on rodents shows that a high-fat diet enriched with oligofructose causes a decrease in energy intake, less weight gain and a lower level of triglycerides . A similar effect has been observed in healthy adults. Available evidence suggests that the addition of oligofructose to the diets of overweight or obese adults may increase satiety and thus reduce energy intake. Currently, there are no data on the effect of oligofructose in overweight and obese children.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Maltodextrin | Placebo Comparator |
| |
| Oligofructose | Experimental | Orafti P95, Beneo-Orafti, Belgium, |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Oligofructose | Dietary Supplement | Dosing: children aged 7 to 12 years: 8g/day, children aged 12 to18 years: 15g/day Duration: 12 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| BMI z-score difference | after 12 weeks of the intervention |
| Measure | Description | Time Frame |
|---|---|---|
| BMI z-score difference | after 24 weeks of the intervention | |
| Percentage of weight reduction | after 12 weeks of the intervention | |
| Difference in total body fat measured by Dual-Energy X-ray Absorptiometry (DEXA) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Samodzielny Publiczny Dziecięcy Szpital Kliniczny | Warsaw | Poland |
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| D050177 | Overweight |
| ID | Term |
|---|---|
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
Not provided
Not provided
| ID | Term |
|---|---|
| C120489 | oligofructose |
| C008315 | maltodextrin |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Maltodextrin | Dietary Supplement | Dosing: children aged 7 to 12 years: 4g/day, children aged 12 to18 years: 6g/day, Duration: 12 weeks |
|
| after 12 weeks of the intervention |
| Percentage of children with BMI-for-age > 85percentile | after 12 and 24 weeks of the intervention |
| Mean BMI z-score | after 12 and 24 weeks of the intervention |
| Self-reported energy intake (3-day diet record) | after 12 weeks of the intervention |
| Percentage of the children with abnormal fasting glucose | after 12 weeks of the intervention |
| Percentage of the children with dyslipidemias | after 12 weeks of the intervention |
| Percentage of the children with hypertension | after 12 weeks of the intervention |
| Adverse effects | during intervention |
| D012816 |
| Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |